Cyclic strain has antifibrotic effects on the human cardiac fibroblast transcriptome in a human cardiac fibrosis-on-a-chip platform.

[1]  M. Goumans,et al.  Pirfenidone Has Anti-fibrotic Effects in a Tissue-Engineered Model of Human Cardiac Fibrosis , 2022, Frontiers in Cardiovascular Medicine.

[2]  F. Spinale,et al.  Does the Heart Want What It Wants? A Case for Self-Adapting, Mechano-Sensitive Therapies After Infarction , 2021, Frontiers in Cardiovascular Medicine.

[3]  A. Khademhosseini,et al.  Advanced in vitro modeling to study the paradox of mechanically induced cardiac fibrosis. , 2021, Tissue engineering. Part C, Methods.

[4]  N. Frangogiannis,et al.  The role of Smad signaling cascades in cardiac fibrosis. , 2020, Cellular Signalling.

[5]  A. McCulloch,et al.  Maintaining resting cardiac fibroblasts in vitro by disrupting mechanotransduction , 2020, PloS one.

[6]  Joseph C. Wu,et al.  Generation of Quiescent Cardiac Fibroblasts from Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis. , 2019, Circulation research.

[7]  C. Zuppinger.  3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications , 2019, Front. Cardiovasc. Med..

[8]  Yu Sun,et al.  Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug screening , 2019, bioRxiv.

[9]  M. Mayr,et al.  Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology , 2019, European journal of heart failure.

[10]  N. Frangogiannis.  Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. , 2019, Molecular aspects of medicine.

[11]  Y. S. Zhang,et al.  Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation , 2019, Advanced healthcare materials.

[12]  Carsten Grashoff,et al.  Unforgettable force – crosstalk and memory of mechanosensitive structures , 2018, Biological chemistry.

[13]  Milena B. Furtado,et al.  The interstitium in cardiac repair: role of the immune–stromal cell interplay , 2018, Nature Reviews Cardiology.

[14]  Joseph G Ibrahim,et al.  Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences , 2018, bioRxiv.

[15]  A. Khademhosseini,et al.  Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis , 2019, Front. Cardiovasc. Med..

[16]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[17]  J. Thomson,et al.  Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors , 2017, Nature Communications.

[18]  S. V. Heesch,et al.  IL-11 is a crucial determinant of cardiovascular fibrosis , 2017, Nature.

[19]  A. McCulloch,et al.  Mechanical regulation of cardiac fibroblast profibrotic phenotypes , 2017, Molecular biology of the cell.

[20]  A. Khademhosseini,et al.  Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling , 2017, Advanced healthcare materials.

[21]  A. McCulloch,et al.  The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart , 2017, Journal of clinical medicine.

[22]  A. Khademhosseini,et al.  Modeling the Human Scarred Heart In Vitro: Toward New Tissue Engineered Models , 2017, Advanced healthcare materials.

[23]  B. Lim,et al.  A Transcriptomic and Epigenomic Comparison of Fetal and Adult Human Cardiac Fibroblasts Reveals Novel Key Transcription Factors in Adult Cardiac Fibroblasts , 2016, JACC. Basic to translational science.

[24]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[25]  Milica Radisic,et al.  Distilling complexity to advance cardiac tissue engineering , 2016, Science Translational Medicine.

[26]  Joshua D. Hutcheson,et al.  Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. , 2016, Journal of molecular and cellular cardiology.

[27]  B. Hinz,et al.  Mechanical control of cardiac myofibroblasts. , 2016, Journal of molecular and cellular cardiology.

[28]  Guangchuang Yu,et al.  ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. , 2016, Molecular bioSystems.

[29]  Marco Rasponi,et al.  Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. , 2016, Lab on a chip.

[30]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[31]  Yu Sun,et al.  Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. , 2014, Lab on a chip.

[32]  Mark W. Tibbitt,et al.  Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway , 2013, Proceedings of the National Academy of Sciences.

[33]  Chris B Schaffer,et al.  Cyclic strain anisotropy regulates valvular interstitial cell phenotype and tissue remodeling in three-dimensional culture. , 2012, Acta biomaterialia.

[34]  Russell A. Gould,et al.  Interactions between TGFβ1 and cyclic strain in modulation of myofibroblastic differentiation of canine mitral valve interstitial cells in 3D culture. , 2012, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology.

[35]  A. Khademhosseini,et al.  Cell-laden microengineered gelatin methacrylate hydrogels. , 2010, Biomaterials.

[36]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[37]  Michael S Sacks,et al.  Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. , 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[38]  C. Baicu,et al.  Cardiac myofibroblasts differentiated in 3D culture exhibit distinct changes in collagen I production, processing, and matrix deposition. , 2006, American journal of physiology. Heart and circulatory physiology.

[39]  A. Poustka,et al.  Parameter estimation for the calibration and variance stabilization of microarray data , 2003, Statistical applications in genetics and molecular biology.

[40]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[41]  R. Tibshirani.  Estimating Transformations for Regression via Additivity and Variance Stabilization , 1988 .

[42]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[43]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[44]  P. Galie,et al.  Interstitial fluid flow and cyclic strain differentially regulate cardiac fibroblast activation via AT1R and TGF-β1. , 2012, Experimental cell research.

[45]  Gerard Pasterkamp,et al.  Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury. , 2004, Cardiovascular research.